ARCHIVES

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

This article is from The Cancer Letter archive.

Vol. 30 No. 31 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

Adriamycin Fact Sheet Available

July 4, 1975

ACCC Seeks Greater Role In Clinical Research Priorities; Suggests Up To 400 Cancer Program

April 13, 1979

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976

Varmus, In Letter To Institute Pasteur, Reopens Discussion Of Test Kit Royalties

July 1, 1994

House Committee Approves $1.9 Bil. NCI Budget

July 31, 1992

Concepts Approved For $26.5Million In DCPC contracts, Including Heavy Smoker Program

February 1, 1985